Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.

ABSTRACT:

SUBMITTER: Cantini F 

PROVIDER: S-EPMC7313480 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature